小摩增持信达生物(01801)约255.05万股 每股作价约80.68港元

Group 1 - The core point of the article is that JPMorgan has increased its stake in Innovent Biologics (01801) by purchasing 2.550546 million shares at a price of HKD 80.6819 per share, totaling approximately HKD 206 million [1] - After the purchase, JPMorgan's total shareholding in Innovent Biologics is approximately 87.0232 million shares, representing a holding percentage of 5.07% [1]